ArticleMolecular oncology2022

USP28 enables oncogenic transformation of respiratory cells, and its inhibition potentiates molecular therapy targeting mutant EGFR, BRAF and PI3K.

Cristian Prieto-Garcia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.